Vimarsana
Biggest News Aggregation in the World

Page 2 - Kidney D News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kidney D. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kidney D Today - Breaking & Trending Today

KNTV NBC Nightly News With Lester Holt June 4, 2024 23:17:00 - Vimarsana News

KNTV NBC Nightly News With Lester Holt June 4, 2024 23:17:00

And d here. and hehere. nonot so much h here. if you'v've been diaiagnosedeh chroninic kidney d disease farxiga a reduces ththe risk ofof kidney fafailure whwhich can lelead to dialaly. farxiga cacan cause seseriouse effectcts includining dehydrat, ururinary tracact or genitil yeast t infectionsns in women a and men, and low blblood sugar.r. ketotoacidosis is a serioious side efeffet that may l lead to deaeath. a a rare life-e-threateninig bactererial infectction inin the skin n of the pererim cocould occur.r. stopop taking fafarxiga and l your dococtor right t away ifif you have e symptoms of...

KNTV NBC Nightly News With Lester Holt June 4, 2024 23:17:00 - Vimarsana News

KNTV NBC Nightly News With Lester Holt June 4, 2024 23:17:00

To mental health, open up the conversations, but to hopefully help people to feel comfortable asking for that help. >> reporter: all while trying to explain the inexplicable to their three children. >> to us daddy is in the stars so we can go outside and talk to him whenever we want. >> reporter: so he will always shine. anne thompson, nbc news. >> if you or anyone you know is struggling, you can call the national suicide and crisis lifeline at 988. still ahead, the new crackdown on knockoff versions of popular weight loss drugs. what you need to know drugs. what you need to know next. whene...

More Evidence Salt Substitutes Lower Risk of CVD and Death - Vimarsana News

More Evidence Salt Substitutes Lower Risk of CVD and Death

The blood pressure–lowering effects of dietary salt substitutes have a clear protective effect on hard clinical outcomes, leading to a reduction in heart attack, stroke, and death, a meta-analysis shows.

Avacopan Shows Efficacy Signal for Rare Kidney Disease, C3G - Vimarsana News

Avacopan Shows Efficacy Signal for Rare Kidney Disease, C3G

Avacopan, recently FDA approved for ANCA-associated vasculitis, showed significant benefit for reducing disease chronicity in a randomized trial of 52 patients with C3 glomerulopathy.

Higher BMI Increases Risk of Diabetic Kidney Disease - Vimarsana News

Higher BMI Increases Risk of Diabetic Kidney Disease

Higher BMI was associated with increased risk of diabetic nephropathy and decreased eGFR, particularly in women, in new research.